DK0772438T3 - Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling - Google Patents

Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling

Info

Publication number
DK0772438T3
DK0772438T3 DK95930892T DK95930892T DK0772438T3 DK 0772438 T3 DK0772438 T3 DK 0772438T3 DK 95930892 T DK95930892 T DK 95930892T DK 95930892 T DK95930892 T DK 95930892T DK 0772438 T3 DK0772438 T3 DK 0772438T3
Authority
DK
Denmark
Prior art keywords
benzothiophenes
medicament
manufacture
wound healing
during wound
Prior art date
Application number
DK95930892T
Other languages
Danish (da)
English (en)
Inventor
George Joseph Cullinan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0772438T3 publication Critical patent/DK0772438T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95930892T 1994-08-22 1995-08-21 Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling DK0772438T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/293,851 US5550151A (en) 1994-08-22 1994-08-22 Methods of reducing scarring in wound healing
PCT/US1995/010650 WO1996005826A1 (en) 1994-08-22 1995-08-21 Methods of reducing scarring in wound healing

Publications (1)

Publication Number Publication Date
DK0772438T3 true DK0772438T3 (da) 1999-11-01

Family

ID=23130857

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95930892T DK0772438T3 (da) 1994-08-22 1995-08-21 Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling

Country Status (14)

Country Link
US (1) US5550151A (es)
EP (1) EP0772438B1 (es)
JP (1) JPH10504823A (es)
AT (1) ATE179890T1 (es)
AU (1) AU3411195A (es)
CA (1) CA2198011A1 (es)
DE (1) DE69509657T2 (es)
DK (1) DK0772438T3 (es)
ES (1) ES2131331T3 (es)
GR (1) GR3030255T3 (es)
IL (1) IL115023A0 (es)
MX (1) MX9701328A (es)
WO (1) WO1996005826A1 (es)
ZA (1) ZA956995B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4688046B2 (ja) * 2004-11-05 2011-05-25 株式会社ポーラファルマ 肥厚性瘢痕動物モデル

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体

Also Published As

Publication number Publication date
JPH10504823A (ja) 1998-05-12
EP0772438B1 (en) 1999-05-12
MX9701328A (es) 1997-05-31
IL115023A0 (en) 1995-12-08
GR3030255T3 (en) 1999-08-31
DE69509657T2 (de) 1999-09-30
AU3411195A (en) 1996-03-14
EP0772438A1 (en) 1997-05-14
DE69509657D1 (de) 1999-06-17
CA2198011A1 (en) 1996-02-29
WO1996005826A1 (en) 1996-02-29
EP0772438A4 (en) 1997-09-03
ZA956995B (en) 1997-02-21
US5550151A (en) 1996-08-27
ATE179890T1 (de) 1999-05-15
ES2131331T3 (es) 1999-07-16

Similar Documents

Publication Publication Date Title
DK0771200T3 (da) Anvendelse af raloxifen og dets analoger til fremstilling af et medikament til behandling af virale sygdomme
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
DK0652002T3 (da) Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
DK0772438T3 (da) Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling
PH31620A (en) Benzothiophenes for bone healing and fracture repair.
MX9701333A (es) Metodos para inhibir el daño neuronal.
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
MX9701327A (es) Metodos para inhibir el cancer endometrial.
DK0771201T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.
MX9705940A (es) Metodos y composiciones para inhibir los efectos de la interleucina 6.
MX9705215A (es) Uso de 2-fenil-3-aroilbenzotiofenos para inhibir los efectos de la hormona del crecimiento.
MX9709651A (es) Metodos para modulacion del factor de transcripcion nf-kb.
MX9702861A (es) Metodo para inhibir las condiciones asociadas con la bradicinina.
MX9702853A (es) Metodos para inhibir condiciones asociadas con el neuropeptido "y".
MX9706520A (es) Metodos para inhibir el cancer de ovario.